Furthermore, this study highlights the value of VAT measurement as a more accurate indicator of obesity than BMI and demonstrates that an increase in VAT could be associated with a better prognosis in metastatic ER+/HER2- BC patients. The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.